Position in KRYS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$120,701,689
+$55,767,017 QoQ
Shares Held
324,755
+29.2% QoQ
Ownership
1.10%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#18
of 419 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 0%
Shared 98%
None 2%
Common Shares in KRYS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Invesco Ltd. holds $14,221,834,024 across 296 Biotechnology names. KRYS ranks #20 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,043,052 | $3,995,225,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,940,665 | $2,457,162,245 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,754,318 | $1,130,162,341 | |
| 4 | INCY |
Incyte Corp
|
4,080,461 | $462,561,050 | |
| 5 | ARGX |
Argenx SE
|
443,990 | $411,920,598 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
1,671,684 | $409,178,086 | |
| 7 | MRNA |
Moderna, Inc.
|
5,780,299 | $404,794,337 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
1,201,644 | $379,827,645 |
All Filings in KRYS
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $120,701,689 | 324,755 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $64,934,672 | 251,373 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $14,794,371 | 60,008 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $11,806,324 | 66,880 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $9,744,261 | 70,888 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $45,883,822 | 254,486 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $43,112,046 | 275,195 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $66,541,246 | 365,551 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $50,515,138 | 275,077 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $15,947,507 | 89,628 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $6,727,648 | 54,229 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $5,127,084 | 44,199 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $7,655,418 | 65,208 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $4,129,493 | 51,580 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $2,221,565 | 28,043 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $3,597,076 | 51,608 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $601,050 | 9,154 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $515,683 | 7,750 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $537,285 | 7,681 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $424,779 | 8,136 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $489,940 | 7,205 | Shares | Defined | 2021-08-17 | |
| 2021-03-31 | $288,976 | 3,751 | Shares | Defined | 2021-05-17 | |
| 2020-03-31 | $1,500,470 | 34,701 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||